The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Revance Therapeutics, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ:RVNC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder […]

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Rentokil Initial plc

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rentokil Initial plc ("Rentokil" or "the Company") (NYSE:RTO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into MediaAlpha, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MediaAlpha, Inc. ("MediaAlpha" or "the Company") (NYSE:MAX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

February 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against – SAVA

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=124389&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

InventHelp Inventor Develops Toothbrush for Those with Compromised Hand Strength (DCD-386)

“I wanted to create an improved toothbrush that would be easier to grip and hold, especially for those who have compromised hand strength,” said an inventor, from District Heights,Md., “so I invented the ORAL HYGIENIC DEVICES. My design helps prevent the user from dropping the toothbrush, and it may increase independence.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued

Adam Ferrari Announces Annie O’Brien as the 2024 Recipient of the Adam Ferrari Health Science Scholarship

DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) — The Ferrari Foundation is proud to announce Annie O'Brien, a nursing student at Marquette University, as the 2024 recipient of the Adam Ferrari Health Science Scholarship. Selected from a highly competitive pool of applicants, Annie impressed the scholarship committee with her academic excellence, dedication to healthcare, and her

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira

(NASDAQ:PCRX), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pacira To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Pacira between August 2, 2023 and August 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner

Scroll to Top